期刊文献+

以甲状旁腺功能减退为表型的DiGeorge综合征1例及文献复习 被引量:2

A case of DiGeorge syndrome with hypoparathyroidism as a phenotype and review of literature
下载PDF
导出
摘要 目的探索22q11.2微缺失综合征的临床表型及治疗经验。方法总结兰州大学第一医院儿内科2020年6月收治的1例以甲状旁腺功能减退为表型的DiGeorge综合征的诊治过程,并复习总结国内外相关病例的诊疗过程。结果病儿主诉间断可疑抽搐10余天。入院完善相关检查以及基因检测后,诊断为DiGeorge综合征伴甲状旁腺功能减退、继发性癫痫;经给予钙剂、骨化三醇及左乙拉西坦等对症治疗,病儿病情好转后出院,院外随访半年内病儿无抽搐发作。结论补钙是目前治疗以甲状旁腺功能减退为表型的DiGeorge综合征的关键措施。 Objective To explore the clinical phenotype and treatment experience of 22q11.2 microdeletion syndrome.Methods The diagnosis and treatment process of a case of DiGeorge syndrome with hypoparathyroidism as phenotype admitted to the Department of Pediatrics,the First Hospital of Lanzhou University in June 2020 were summarized,and literature regarding the diagnosis and treatment process of related cases at home and abroad were reviewed.Results The child complained of intermittent suspicious convulsions for more than 10 days.After completion of relevant examinations and genetic tests,she was diagnosed as DiGeorge syndrome with hypoparathyroidism and secondary epilepsy.After receiving symptomatic treatment such as calcium,calcitriol and levetiracetam,the patient was discharged after improvement of condition.During the six-month out-of-hospital follow-up,the child did not have convulsions.Conclusion Calcium supplementation is the key measure for the treatment of DiGeorge syndrome with hypoparathyroidism.
作者 师丛 闫小莉 叶新华 SHI Cong;YAN Xiaoli;YE Xinhua(The First Clinical Medical College of Lanzhou University,Lanzhou,Gansu 730000,China;Department of Pediatric Medicine,The First Hospital of Lanzhou University,Lanzhou,Gansu 730030,China)
出处 《安徽医药》 CAS 2022年第8期1607-1610,共4页 Anhui Medical and Pharmaceutical Journal
关键词 DIGEORGE综合征 甲状旁腺功能低下 22q11.2微缺失综合征 DiGeorge syndrome Hypothyroidism 22Q11.2 Microdeletion syndrome
  • 相关文献

参考文献4

二级参考文献21

  • 1Cancrini C, Puliafito P, Digilio MC, et al. Clinical features and follow-up in patients with 22q11.2 deletion syndrome [ J]. J Pediatr, 2014,164 (6) :1475 - 1480.
  • 2Grassi MS,Jacob CM, Kulikowski LD, et al. Congenital heart disease as a warning sign for the diagnosis of the 22q11.2 deletion [ J ]. Arq Bras Cardio1,2014,103 ( 5 ) :382 - 390.
  • 3Digilio M, Marino B, Capolino R, et al. Clinical manifestations of Dele- tion 22q11.2 syndrome ( DiGeorge/Velo-Cardio-Facial syndrome) [ J ]. Images Paediatr Cardio1,2005,7 (2) :23 -34.
  • 4Del Carmen Montes C, Sturich A, Chaves A, et al. Clinical findings in 32 patients with 22q11.2 mierodeletion attended in the city of Cordoba, Ar- gentina [ J ]. Arch Argent Pediatr,2013,111 ( 5 ) :423 - 427.
  • 5Monteiro FP,Vieira TP, Sgardioli IC, et al. Defining new guidelines for screening the 22ql 1.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature [ J ]. Eur J Pediatr,2013,172 ( 7 ) : 927 - 945.
  • 6Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syn- drome:the chromosome 22q11. 2 deletion syndromes [ J]. Lancet, 2007,370(9596) :1443 - 1452.
  • 7Cuneo BF. 22q11.2 deletion syndrome : DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes [ J ]. Curr Opin Pediatr, 2001,13 ( 5 ) :465 - 472.
  • 8Mcdonald R, Dodgen A, Goyal S, et al. Impact of 22q11.2 deletion on the postoperative course of children after cardiac surgery [ J ]. Pediatr Cardiol,2013,34(2) :341 -347.
  • 9Leopold C,de Barros A,Cellier C,et al. Laryngeal abnormalities are fre- quent in the 22q11 deletion syndrome [ J ]. Int J Pediatr Otorhinolaryngol, 2012,76( 1 ) :36 -40.
  • 10Cheung EN, George SR, Costain GA, et al. Prevalence of hypocalcaemia and its associated features in 22q11. 2 deletion syndrome [ J ]. Clin Endoerinol (Oxf) ,2014,81 (2) :190 - 196.

共引文献26

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部